Simulations Plus Sets Date for 2nd Quarter 2019 Earnings Release and Conference Call

Conference Call to be on Tuesday, April 9, 2019, at 4:15 PM ET

LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to
file its quarterly report on Form 10-Q for the second quarter of its
2019 fiscal year, the period ended February 28, 2019, on Tuesday, April
9, 2019.

The Company will host a conference call on April 9, 2019, at 4:15 p.m.
Eastern Time. All interested parties are invited to join the call by
registering here.
On registering, you will receive a confirmation e-mail with instructions
for joining the call. Please dial in five to ten minutes prior to the
scheduled start time. For listen-only mode, you may dial (415) 930-5321,
and enter access code 271-105-468. A replay will be available at the
Simulations Plus website
following the call.

About Simulations Plus, Inc.

Simulations Plus, Inc., is a premier developer of drug discovery and
development software as well as a leading provider of both preclinical
and clinical pharmacometric consulting services for regulatory
submissions. The company is a global leader focused on improving the
ways scientists use knowledge and data to predict the properties and
outcomes of pharmaceutical and biotechnology agents. Our software is
licensed to and used in the conduct of drug research by major
pharmaceutical and biotechnology companies and regulatory agencies
worldwide. Our innovations in integrating new and existing science in
medicinal chemistry, computational chemistry, pharmaceutical science,
biology, and physiology into our software have made us the leading
software provider for physiologically based pharmacokinetic modeling and
simulation. For more information, visit our website at www.simulations-plus.com.

Contacts

Simulations Plus Investor Relations
Ms.
Renee Bouche
661-723-7723
[email protected]

Hayden IR
Mr. Cameron Donahue
651-653-1854
[email protected]